GENOMIC SEQUENCING | Our genomic tests analyze DNA, RNA, and proteomic data to understand a patient's tumor at the molecular level so we can identify treatment options tailored to each and every patient. |
CLINICAL DATA STRUCTURING | We ingest and organize clinical notes, lab reports, pathology images, and radiology scans to capture phenotypic, therapeutic and outcomes data to understand the clinical context for each patient case. |
IMAGE RECOGNITION | Advanced image recognition algorithms extract key characteristics from radiology and pathology images to quantitatively measure treatment responses and create the building blocks for augmented intelligence applications. |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
G轮 | 2020-03 | Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, plus funds and accounts managed by T. Rowe Price. | 1亿美元 |
G-2轮 | 2020-12 | Baillie Gifford,Franklin Templeton,Google,Novo Holdings,以及由T. Rowe Price管理的基金和帐户 | 2亿美元 |